Approval · Notice of Compliance 31654 · 2023
EUCRISA: Notice of Compliance 31654
Issued September 19, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31654
- Date
- September 19, 2023
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a drug substance manufacturer. Change in the manufacturing process
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EUCRISA | Not yet assigned | — |
Medicinal ingredients
- CRISABOROLE 2 PER